Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Vet Immunol Immunopathol ; 262: 110632, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37517103

ABSTRACT

Dexamethasone (DEXA) is a potent corticosteroid, commonly used for treating inflammatory, hypersensitive and allergic conditions. It is administered to birds with tumours. Many studies were conducted on its immunosuppressive effects; however none of the similar study is available employing chicken splenocytes culture system. The present study was conducted to assess DEXA induced alterations in inflammatory and oxidative stress biomarkers in chicken splenocytes due to its in vitro exposure. The maximum non-cytotoxic dose (MNCD) was evaluated and was further used for conducting lymphocytes proliferation assay (LPA), antioxidant assays (lipid peroxidation, GSH, superoxide dismutase and nitric oxide assays) and assessment of mRNA levels of various genes (IL-1ß, IL-6, IL-10, LITAF, iNOS, NF-κB1, Nrf-2, Caspase-3 and -9) through qPCR. The MNCD was determined to be 30 ng/ml in chicken splenocytes culture system. DEXA caused reduction in B and T lymphocytes proliferation indicating its immunosuppressive effects, however improved the antioxidant status of the exposed splenocytes. The expression levels of IL-1ß, IL-6, iNOS, LITAF and NF-κB1 were significantly reduced while IL-10 was enhanced, which signify potent anti-inflammatory potential of DEXA. NF-κB is a major transcription factor that regulates genes responsible for both, innate and adaptive immune responses and elicits inflammation. The nuclear factor erythroid 2-related factor 2 (Nrf-2) level was found to be up-regulated. Nrf-2 plays important role in combating the oxidant stress and its increased expression could be the reason of improved antioxidant status of DEXA exposed cells. Present findings indicated that DEXA exhibited modulation in anti-inflammatory, immunomodulatory and antioxidant mediators in chicken splenocytes.


Subject(s)
Antioxidants , Interleukin-10 , Animals , Interleukin-10/metabolism , Antioxidants/metabolism , Chickens/metabolism , Interleukin-6/metabolism , Spleen/pathology , Oxidative Stress , NF-kappa B/metabolism , Anti-Inflammatory Agents/pharmacology , Dexamethasone/pharmacology , Cytokines/genetics , Cytokines/metabolism
2.
J Inflamm (Lond) ; 17: 15, 2020.
Article in English | MEDLINE | ID: mdl-32336953

ABSTRACT

Dynamic interactions between the gastrointestinal epithelium and the mucosal immune system normally contribute to ensuring intestinal homeostasis and optimal immunosurveillance, but destabilisation of these interactions in genetically predisposed individuals can lead to the development of chronic inflammatory diseases. Ulcerative colitis is one of the main types of inflammatory diseases that affect the bowel, but its pathogenesis has yet to be completely defined. Several genetic factors and other inflammation-related genes are implicated in mediating the inflammation and development of the disease. Some susceptibility loci associated with increased risk of ulcerative colitis are found to be implicated in mucosal barrier function. Different biomarkers that cause damage to the colonic mucosa can be detected in patients, including perinuclear ANCA, which is also useful in distinguishing ulcerative colitis from other colitides. The choice of treatment for ulcerative colitis depends on disease severity. Therapeutic strategies include anti-tumour necrosis factor alpha (TNF-α) monoclonal antibodies used to block the production of TNF-α that mediates intestinal tract inflammation, an anti-adhesion drug that prevents lymphocyte infiltration from the blood into the inflamed gut, inhibitors of JAK1 and JAK3 that suppress the innate immune cell signalling and interferons α/ß which stimulate the production of anti-inflammatory cytokines, as well as faecal microbiota transplantation. Although further research is still required to fully dissect the pathophysiology of ulcerative colitis, understanding its cellular pathology and molecular mechanisms has already proven beneficial and it has got the potential to identify further novel, effective targets for therapy and reduce the burden of this chronic disease.

3.
Int J Med Mushrooms ; 17(4): 351-60, 2015.
Article in English | MEDLINE | ID: mdl-25954961

ABSTRACT

Diabetes mellitus is one of the most common endocrine diseases. One antidiabetic therapeutic approach is to reduce gastrointestinal glucose production and absorption through the inhibition of α-amylase and α-amyloglucosidase enzymes, thereby preventing an increase in the postprandial glucose concentration in diabetics. The main aim of this study was to evaluate the antidiabetic potential of hydroalcoholic extracts of 3 mushrooms, that is, Ganoderma philippii, Lenzites elegans, and Rigidoporus ulmarius, using an in vitro enzymatic starch digestion assay model. The α-amylase and α-glucosidase inhibitory potential of hydroalcoholic mushroom extracts was tested at concentrations of 1, 5, 10, 12.5, 25, 50, and 100 mg/mL. Acarbose was used as a control. The amount of glucose liberated (micrograms) was determined using the 3,5-dinitrosalicylic acid method. Phytochemical screening revealed the presence of carbohydrates in all examined species. In the case of G. philippii and L. elegans, a concentration-dependent increase in the percentage inhibition of enzyme activity was observed, with maximum inhibition at a concentration of 100 mg/mL (40.22% ± 0.83% and 26.57% ± 0.68%, respectively). R. ulmarius showed maximum inhibitory activity at a concentration of 100 mg/mL (65.54% ± 0.91%), and this was comparable to acarbose.


Subject(s)
Carbohydrate Metabolism , Complex Mixtures/pharmacology , Coriolaceae/chemistry , Enzyme Inhibitors/pharmacology , Ganoderma/chemistry , Hypoglycemic Agents/pharmacology , Complex Mixtures/isolation & purification , Enzyme Inhibitors/isolation & purification , Humans , Hypoglycemic Agents/isolation & purification , India , alpha-Amylases/antagonists & inhibitors , alpha-Glucosidases/metabolism
4.
J Econ Entomol ; 104(6): 1999-2008, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22299363

ABSTRACT

The radiation biology of two geographically isolated populations of the light brown apple moth [Epiphyas postvittana (Walker)] was studied in Australia and New Zealand as an initiation of a SIT/F1 sterility program. Pharate and < or = 2 d pre-emergence pupae were exposed to increasing radiation doses up to a maximum dose of 300 Gy. Fertility and other life history parameters were measured in emerging adults (parental) and their progeny (F1-F3 adults). Parental fecundity was significantly affected by increasing irradiation dose in pharate pupae only. For both populations, parental egg fertility declined with increasing radiation. This was most pronounced for the irradiated parental females whose fertility declined at a higher rate than of irradiated males. At 250 Gy, females < or = 2 d preemergence pupae produced few larvae and no adults at F1. No larvae hatched from 250 Gy-irradiated female pharate pupae. At 300 Gy, males still had residual fertility of 2-5.5%, with pharate pupae being the more radio-sensitive. Radiation-induced deleterious inherited effects in offspring from irradiated males were expressed as increased developmental time in F1 larvae, a reduction in percent F1 female survival, decreased adult emergence and increased cumulative mortality over subsequent generations. Males irradiated at > or = 150 Gy produced few but highly sterile offspring at F1 and mortality was > 99% by F2 egg.


Subject(s)
Gamma Rays , Moths/radiation effects , Pest Control, Biological/methods , Animals , Dose-Response Relationship, Radiation , Female , Fertility , Male , Mortality , New Zealand , Pupa/radiation effects , Reproduction , Western Australia
SELECTION OF CITATIONS
SEARCH DETAIL
...